CimetrA

N/A

Report date: 2025/05/20 20:00:09
NME

Base Information

Drug NameCimetrA
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)InflammationCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMgc Pharmaceuticals Doo
China Registration ClassN/A

Develop Information

Active CompaniesArgent Biopharma LtdMgc Pharmaceuticals Doo
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)InflammationCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A